GENOUS
LIVE

Serial Number

98755109

Owner

GENOMATE HEALTH INC.

Attorney

Sudip K. Mitra

Filing Date

Sep 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GENOUS Trademark

Serial Number: 98755109

GENOUS is a trademark filed by GENOMATE HEALTH INC. on September 17, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

GENOMATE HEALTH INC. (6 trademarks)

1 BROADWAY
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

September 17, 2024

Registration Date

Not Registered

Goods & Services

Genetic testing for medical purposes; Genetic testing for cancer risk for medical purposes; Genetic testing for medical purposes for detecting genetic predispositions; Genetic counseling; Medical counseling for the medical treatment of genetic predispositions; Providing information about genetic counseling; Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized end-to-end precision oncology therapy services, clinical decision support services in the nature of precision oncology decision-support reports based on tumor sequencing data and support services for healthcare professionals and patients in the nature of enabling evidence-based treatment decisions for healthcare professionals and patients via secure online platform and electronic delivery of clinical reports; Consulting services in the field of health care to assist with biomedical and clinical decisions; Medical diagnostic testing, monitoring and reporting services in the field of personalized medicine; Genetic sequencing for medical purposes

Biological research and analysis; Medical research services; Scientific research, namely scientific research relating to genetic alterations; Research in the field of genetic diseases; Consulting services in the field of genetic science; Genetic sequencing services for scientific purposes; Providing medical research information in the field of genetics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing for disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Providing medical and scientific research information in the fields of pharmaceuticals and genetics

Filing History

TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 5, 2026 ERFR
EX PARTE APPEAL-INSTITUTED
Jun 5, 2026 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 5, 2026 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 5, 2026 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 5, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 5, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 5, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 5, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 5, 2025 CNFR
EXAMINER'S AMENDMENT ENTERED
Dec 3, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 3, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 3, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 3, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2025 TROA
NOTICE OF REVIVAL - E-MAILED
Nov 20, 2025 NREV
PETITION TO REVIVE-GRANTED
Nov 20, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 20, 2025 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 6, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 20, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 20, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2025 NWOS
NEW APPLICATION ENTERED
Sep 17, 2024 NWAP